Women in their thirties are most likely to be mistrustful of the COVID-19 vaccine, according to government research. A survey of 1000 Australians found 42 per cent of women aged 30 to 39 had concerns about the safety of the COVID-19 vaccine, the Sydney Morning Herald reported. Overall, 27 per cent of the population had… Read More »
As the world eagerly awaits the first doses of a coronavirus vaccine being rolled out, some in Sweden are watching with trepidation. For Meissa Chebbi, 21, who like hundreds of other young Swedes suffered debilitating narcolepsy after a mass vaccination campaign against the 2009-2010 swine flu pandemic, the vaccine is not something she will be… Read More »
With more than 180 COVID-19 vaccines currently in development1 — 53 of them undergoing clinical trials in humans2 — manufacturers are racing to be the first to reach the market. Pfizer, in a joint venture with Germany-based BioNTech, may have just taken the lead, with an announcement that their mRNA-based vaccine candidate, BNT162b2, was “more… Read More »
By Adam Vaughan A biologist takes a coronavirus DNA sample from the freezer at the Technological Vaccine Center of the Federal University of Minas Gerais, in Belo Horizonte, Brazil.Pedro Vilela/Getty Images We have a covid-19 vaccine that works. But can we keep it cold enough to get it to enough people? Among Pfizer and BioNTech’s… Read More »
As the first coronavirus vaccines arrive in the coming year, government researchers will face a monumental challenge: monitoring the health of hundreds of millions of Americans to ensure the vaccines don’t cause harm. Purely by chance, thousands of vaccinated people will have heart attacks, strokes and other illnesses shortly after the injections. Sorting out whether… Read More »